[1]
“Vascular endothelial growth factor inhibitors in exudative retinal diseases: overview of recent advances and prospects for further progress”, Ukr. j. ophthalmol. , no. 4, pp. 58–64, Aug. 2024, doi: 10.31288/oftalmolzh202445864.